Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including other brain neurons; strongest in epididymal clear cells | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 65 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 11692
Sealed predictions
- EPDR1 in dopamine neurons, braak+0.43 (p 0.244) → +0.35 (p 0.361)receipt 11699
Swarm cases
receipt 11699: EPDR1 in dopamine neurons, braak
- power
- full sample +0.28 (p 0.254, n 18), 95% CI -0.21 to +0.66. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.30 (p 0.228, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.28 (p 0.265, n 18). could be the mix.
- skeptic
- leave-one-out range +0.18 to +0.45, sign flips 0; without severely affected donors +0.28 (p 0.254, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for EPDR1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts